U.S. federal trademark · Serial No. 78755226
Pharmaceutical products and preparations in the form of a suspension intravenously administered to the patients for the treatment of thalassemia and sickle cell anemia, for use in connection with bone marrow transplants
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.